作者：
C,Pellegrini [1]
;
S,Raimondi [2]
;
L,Di Nardo [1]
;
P,Ghiorzo [3]
;
C,Menin [4]
;
M A,Manganoni [5]
;
G,Palmieri [6]
;
G,Guida [7]
;
P,Quaglino [8]
;
I,Stanganelli [9]
;
D,Massi [10]
;
L,Pastorino [11]
;
L,Elefanti [4]
;
G,Tosti [5]
;
P,Queirolo [12]
;
A,Leva [12]
;
A,Maurichi [13]
;
M,Rodolfo [13]
;
M C,Fargnoli [14]
;
Italian Melanoma Intergroup (IMI) [1]
作者单位：
Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
[1]
Molecular and Pharmaco-Epidemiology Unit, Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
[2]
Dermatology, Department of Translational Medicine and Surgery, Catholic University of Rome, Italy.
[3]
Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, and Department of Internal Medicine and Medical Specialties, University of Genoa, Italy.
[4]
Immunology and Diagnostic Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.
[5]
Department of Dermatology, Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
[6]
Unit of Cancer Genetics, Istituto di Ricerca Genetica e Biomedica (IRGB), CNR, Sassari, Italy.
[7]
Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari 'A. Moro', Bari, Italy.
[8]
Dermatologic Clinic, Department of Medical Sciences, University of Torino, Turin, Italy.
[9]
Skin Cancer Unit, IRCCS-IRST Scientific Institute of Romagna for the Study and Treatment of Cancer, Meldola and University of Parma, Parma, Italy.
[10]
Department of Health Sciences, University of Florence, Florence, Italy.
[11]
Division of Melanoma, Sarcoma and Rare Cancer, IEO, European Institute of Oncology IRCCS, Milan, Italy.
[12]
Melanoma and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[13]
Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[14]
DOI
10.1111/jdv.17735
PMID
34664323
发布时间
2022-05-31
换一批
换一批
